![]() ![]() ![]() 239000008194 pharmaceutical composition Substances 0.000 claims description 75.238000002360 preparation method Methods 0.000 claims description 157.150000001875 compounds Chemical class 0.000 claims description 273.108090001123 antibodies Proteins 0.000 title claims description 235.102000004965 antibodies Human genes 0.000 title claims description 235.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Family has litigation Priority to US87883107P priority Critical Priority to EP07000211 priority Priority to US93429107P priority Priority to EP07020341 priority Application filed by Univ Zurich filed Critical Univ Zurich Publication of PT2436696T publication Critical patent/PT2436696T/en First worldwide family litigation filed litigation Critical (T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License. Inventor Prof Nitsch Dr Roger Hock Prof Christoph Esslinger Dr Christoph Knobloch Marlen Tissot Kathrin Grimm Dr Jan Original Assignee Univ Zurich Priority date (The priority date is an assumption and is not a legal conclusion. Google Patents PT2436696T - Anti-beta-amyloid antibody and uses thereof PT2436696T - Anti-beta-amyloid antibody and uses thereof
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |